{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:27:14Z","timestamp":1793827634447,"version":"4.6.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>\n                    We describe the imaging findings of a phosphaturic mesenchymal tumor arising in the left maxillary sinus in a 34-year-old woman with persistent hypophosphatemia and elevated parathyroid hormone levels who had undergone repeated evaluation for primary hyperparathyroidism despite negative parathyroid imaging.\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTATATE PET\/CT demonstrated an unexpected somatostatin receptor\u2013avid lesion in this exceptionally rare location. Surgical resection resulted in rapid biochemical and clinical recovery, while histopathology and single-cell RNA sequencing revealed a distinct FGF23- and PHEX-expressing tumor cell population, providing molecular confirmation of the imaging diagnosis.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006696","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:00:45Z","timestamp":1789124445000},"page":"1116-1118","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Occult Maxillary Sinus Phosphaturic Mesenchymal Tumor Localized by 68Ga-DOTATATE PET\/CT After Repeated Negative Parathyroid Imaging"],"prefix":"10.1097","volume":"51","author":[{"given":"Yuyue","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"Hubei Provincial Clinical Medical Research Center for Medical Imaging"},{"name":"Key Laboratory of Biological Targeted Therapy, The Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"Hubei Provincial Clinical Medical Research Center for Medical Imaging"},{"name":"Key Laboratory of Biological Targeted Therapy, The Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration"},{"name":"Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-4361","authenticated-orcid":false,"given":"Xiaotian","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"Hubei Provincial Clinical Medical Research Center for Medical Imaging"},{"name":"Key Laboratory of Biological Targeted Therapy, The Ministry of Education"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.semdp.2019.07.002","article-title":"Phosphaturic mesenchymal tumors: a review and update","volume":"36","author":"Folpe","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"e220185","DOI":"10.1148\/rg.220185","article-title":"Phosphaturic mesenchymal tumor","volume":"43","author":"Barrera","year":"2023","journal-title":"Radiographics"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Rep"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"117640","DOI":"10.1016\/j.bone.2025.117640","article-title":"Integrating single-cell and bulk transcriptome analysis of fibroblast growth factor 23 (FGF23)-producing mesenchymal tumors reveals molecular basis of its secretory phenotype","volume":"201","author":"Gronskaia","year":"2025","journal-title":"Bone"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia","volume":"40","author":"Zhang","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3174\/ajnr.A7513","article-title":"Phosphaturic mesenchymal tumor","volume":"43","author":"Benson","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11926-015-0512-5","article-title":"Tumor-induced osteomalacia: an up-to-date review","volume":"17","author":"Hautmann","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1210\/clinem\/dgad690","article-title":"Clinical characteristics of malignant phosphaturic mesenchymal tumor causing tumor-induced osteomalacia","volume":"109","author":"Abate","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"ziaf040","DOI":"10.1093\/jbmrpl\/ziaf040","article-title":"Gallium-68-DOTATATE PET\/CT for phosphaturic mesenchymal tumor localization in suspected tumor-induced osteomalacia","volume":"9","author":"Hoong","year":"2025","journal-title":"JBMR Plus"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:40Z","timestamp":1793826040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006696","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"2026-07-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}